In Türkiye, the prevalence of type 2 diabetes is above the European average. One of the leading modifiable risk factors behind this picture is obesity. In this article, we examine the obesity–diabetes link and the contribution of weight management — including the gastric balloon — to diabetes management.
How Does Obesity Trigger Type 2 Diabetes?
The insulin resistance chain:
- Visceral fat tissue secretes inflammatory cytokines
- These cytokines impair insulin signaling in the liver and muscle tissue
- Insulin resistance develops — the pancreas is forced to produce more insulin
- Over time, pancreatic capacity becomes insufficient → type 2 diabetes
In people with obesity, the risk of type 2 diabetes is 7 times higher than in normal-weight individuals.
The Effect of Weight Loss on Diabetes
Clinical studies show that even moderate weight loss can significantly improve glycemic control:
- 5–7% body weight loss: Marked reduction in insulin resistance
- 10%+ weight loss: An average 0.5–1.5 point drop in HbA1c
- 15%+ weight loss: Type 2 diabetes remission is possible in some patients
These data have been extensively documented through bariatric surgery (sleeve gastrectomy, bypass); with smaller-scale weight interventions the effect is proportionally smaller but still significant.
The Allurion Program in Diabetic Patients
Allurion is a viable option in well-controlled type 2 diabetes. However, there are points to keep in mind:
Glycemic Monitoring
Because calorie intake decreases during the program, blood sugar may drop. Therefore:
- Those using insulin: dose adjustment may be needed
- Those using sulfonylureas: monitor for hypoglycemia risk
- SGLT-2 inhibitors: risk of ketoacidosis — inform your physician
Expectations for Glycemic Improvement
In the context of the Allurion Program's group mean of 14.9% TBWL (Ienca et al. 2020, PMID: 32279182), there is no large-scale Allurion study directly measuring HbA1c change. From the general literature, it is known that weight loss of this magnitude contributes to glycemic control.
Long-Term Sustainability
The Caballero et al. study (522 patients, PMID: 40676353) showed 95% weight maintenance after 1 year. Long-term weight maintenance is thought to contribute to sustaining glycemic improvement as well.
Individual results may vary. In diabetic patients, the medical decision must be made under the supervision of a specialist physician.
Gastric Balloon vs Other Options for People with Diabetes
| Method | Glycemic Effect | Note |
|---|---|---|
| Lifestyle change | Moderate | Foundational, complements every method |
| GLP-1 RA | Strong (direct effect) | Incretin effect + weight loss |
| Allurion Balloon | Depends on weight loss | Medication adjustment required |
| Bariatric surgery | Marked (depends on weight loss) | Diabetes remission possible; PMID:38804393 |
In a person with type 2 diabetes, the choice of a gastric balloon should be evaluated together with the diabetes physician.
Who Should Be Evaluated More Carefully?
- Insulin-dependent diabetes: Dose adjustment is mandatory and close monitoring is required
- HbA1c > 9%: Glycemic stabilization is recommended first
- History of diabetic gastroparesis: The balloon slows gastric emptying even further — special evaluation
- Intensive use of oral antidiabetics: Monitor for hypoglycemia risk
Summary
Obesity and type 2 diabetes are deeply intertwined. Weight management is an inseparable part of glycemic control. While the Allurion Program is an option in patients with controlled diabetes, coordinate medication management and monitoring requirements with your endocrinology or internal medicine physician.
Further reading:
- Current Options in Obesity Treatment 2026 →
- Who Is the Gastric Balloon Suitable For? →
- Obesity Rates in Türkiye →
- Clinical Evidence →
- Find a Specialist →
This content is for general informational purposes. In diabetic individuals, all treatment decisions should be made in coordination with the relevant specialist physicians.
Authorized Clinics in a City Near You
You can have the Allurion Program performed at more than 60 authorized clinics across Türkiye. For clinics in major cities:
Clinical Sources
Related Articles
Which Weight-Loss Method Is Right for Whom? An Evidence-Based 2026 Comparison Guide
Which weight-loss method is most effective in 2026? Lifestyle, gastric balloon, GLP-1 medications, and bariatric surgery: an evidence-based comparison and a guide to choosing what's right for you.
30 Questions About the Gastric Balloon: Comprehensive Answers and FAQ
The 30 most frequently asked questions about the gastric balloon, with answers based on clinical data. Everything about the procedure, safety, nutrition, pricing, and results.
BMI Calculation: Obesity Classification and Weight Analysis
How is BMI calculated? WHO obesity classification, the meaning of BMI thresholds, and the minimum BMI for a gastric balloon. A practical guide.
Related Pages
Which method is right for you?
Let our specialist physicians evaluate you free of charge.
Free Pre-Assessment →